An investigation into the species formed in the first step of the solvent free homogeneous Michael reaction of alpha,beta-unsaturated ketones with 2-oxocyclopentanecarboxylate (1) is presented. This reaction is catalyzed by FeCl(3).6H(2)O (2) and Fe(ClO(4))(3).9H(2)O (3). EXAFS, XANES, Raman and UV-Vis studies were carried out to explain the experimentally found higher catalytic activity of Fe(ClO(4))(3).9H(2)O (3) compared to FeCl(3).6H(2)O (2). A very intense pre-edge peak is found for a 1.6 mol% solution of FeCl(3).6H(2)O (2) in 1, suggesting a tetrachloroferrate(III) compound to be present in this solution. This is proved by UV-Vis and Raman spectroscopy. The counterion of this anionic complex is an octahedral [Fe(III)(1-H)(2)(H2O2)](+) complex with two deprotonated 2-oxocyclopentanecarboxylate (1) as the chelating ligand, (1-H)(-), as suggested by the examination of the XANES region, the obtained coordination numbers from the EXAFS analysis and by UV-Vis and Raman spectroscopies. In summary, the anion-cation species [Fe(III)Cl(4)](-)[Fe(III)(-H)(2)(H2O2)](+) is formed with FeCl(3).6H(2)O (2), whereas in the case of Fe(ClO(4))(3).9H(2)O (3) XAFS, Raman and UV-Vis investigations suggest the presence of a complex of the form [Fe(III)(1-H)(2)(H2O2)](+)[ClO(4)](-). The obtained results are discussed to explain the reduced catalytic activity of FeCl(3).6H(2)O (2) in comparison to Fe(ClO(4))(3).9H(2)O (3).
No takes yet. Share an insight, caveat, or question.
Bauer et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: